BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 14728050)

  • 21. Surviving heart failure: Robert L. Frye lecture.
    Parmley WW
    Mayo Clin Proc; 2000 Jan; 75(1):111-8. PubMed ID: 10630765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current and newer approaches in the drug treatment of congestive heart failure.
    van Zwieten PA
    Cardiovasc Drugs Ther; 1997 Jan; 10(6):693-702. PubMed ID: 9110112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Drug therapy of cardiac insufficiency: status 1995].
    Rickenbacher P; Buser P; Osswald S; Pfisterer M
    Schweiz Med Wochenschr; 1996 May; 126(21):933-45. PubMed ID: 8693314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta-blockers in heart failure. The 'new wave' of clinical trials.
    Krum H
    Drugs; 1999 Aug; 58(2):203-10. PubMed ID: 10473016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Why beta blockers should be used in heart failure.
    Bhagat K; Hakim JG
    Cent Afr J Med; 1999 Jul; 45(7):187-9. PubMed ID: 10695198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing the treatment of congestive heart failure: diuretics, vasodilators, and angiotensin-converting enzyme inhibitors.
    Chow MS
    Pharmacotherapy; 1993; 13(5 Pt 2):82S-87S. PubMed ID: 8233997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Community pharmacist outreach program directed at physicians treating congestive heart failure.
    Turner CJ; Parfrey P; Ryan K; Miller R; Brown A
    Am J Health Syst Pharm; 2000 Apr; 57(8):747-52. PubMed ID: 10786260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review of randomized trials of digoxin therapy in patients with chronic heart failure.
    Gheorghiade M; Zarowitz BJ
    Am J Cardiol; 1992 Jun; 69(18):48G-62G; discussion 62G-63G. PubMed ID: 1626492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Racial differences in responses to drug treatment: implications for pharmacotherapy of heart failure.
    Taylor JS; Ellis GR
    Am J Cardiovasc Drugs; 2002; 2(6):389-99. PubMed ID: 14727954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of heart failure with preserved systolic function.
    de Groote P; Herpin D; Diévart F; Hanon O; Trochu JN; Artigou JY; Galinier M; Habib G; Juillière Y; Neuder Y; Roudaut R; Komajda M
    Arch Cardiovasc Dis; 2008 May; 101(5):361-72. PubMed ID: 18656095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment with higher dosages of heart failure medication is associated with improved outcome following cardiac resynchronization therapy.
    Schmidt S; Hürlimann D; Starck CT; Hindricks G; Lüscher TF; Ruschitzka F; Steffel J
    Eur Heart J; 2014 Apr; 35(16):1051-60. PubMed ID: 24371079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug therapy for congestive heart failure. Appropriate choices can prolong life.
    Sorrentino MJ
    Postgrad Med; 1997 Jan; 101(1):83-6, 89-90, 93-4. PubMed ID: 9008690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guideline for the management of heart failure caused by systolic dysfunction: part II. Treatment.
    Chavey WE; Blaum CS; Bleske BE; Harrison RV; Kesterson S; Nicklas JM;
    Am Fam Physician; 2001 Sep; 64(6):1045-54. PubMed ID: 11578026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heart failure: highlights from new consensus guidelines.
    Young J
    Cleve Clin J Med; 2000 Jan; 67(1):13-6. PubMed ID: 10645672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drugs, heart failure and quality of life: what are we achieving? What should we be trying to achieve?
    Doba N; Tomiyama H; Nakayama T
    Drugs Aging; 1999 Mar; 14(3):153-63. PubMed ID: 10220102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Temporal trends in pharmacological therapy in the IN-CHF registry from 1995 to 2005].
    Fabbri G; Gorini M; Maggioni AP; Di Lenarda A;
    G Ital Cardiol (Rome); 2007 Feb; 8(2):102-6. PubMed ID: 17402354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of advanced heart failure.
    Van Bakel AB; Chidsey G
    Clin Cornerstone; 2002; 4(6):42-52. PubMed ID: 12739330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beta-Blockers in Children with Congenital Heart Disease Before a Corrective Procedure.
    Buchhorn R
    Rev Recent Clin Trials; 2014; 9(2):61-3. PubMed ID: 25198740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapy of heart failure.
    Schrier RW; Abdallah JG; Weinberger HH; Abraham WT
    Kidney Int; 2000 Apr; 57(4):1418-25. PubMed ID: 10760077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.